688046 Stock Overview
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
GemPharmatech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.65 |
| 52 Week High | CN¥22.45 |
| 52 Week Low | CN¥10.10 |
| Beta | 0.25 |
| 1 Month Change | -8.41% |
| 3 Month Change | -14.02% |
| 1 Year Change | -46.01% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -37.03% |
Recent News & Updates
Shareholder Returns
| 688046 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 7.9% | -3.1% | -1.5% |
| 1Y | -46.0% | -37.9% | -11.8% |
Return vs Industry: 688046 underperformed the CN Life Sciences industry which returned -37.9% over the past year.
Return vs Market: 688046 underperformed the CN Market which returned -11.8% over the past year.
Price Volatility
| 688046 volatility | |
|---|---|
| 688046 Average Weekly Movement | 6.7% |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 688046's share price has been volatile over the past 3 months.
Volatility Over Time: 688046's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 1,506 | Jing Zhao | www.gempharmatech.com |
GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services.
GemPharmatech Co., Ltd. Fundamentals Summary
| 688046 fundamental statistics | |
|---|---|
| Market cap | CN¥4.78b |
| Earnings (TTM) | CN¥157.34m |
| Revenue (TTM) | CN¥638.97m |
30.4x
P/E Ratio7.5x
P/S RatioIs 688046 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688046 income statement (TTM) | |
|---|---|
| Revenue | CN¥638.97m |
| Cost of Revenue | CN¥213.21m |
| Gross Profit | CN¥425.76m |
| Other Expenses | CN¥268.42m |
| Earnings | CN¥157.34m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 66.63% |
| Net Profit Margin | 24.62% |
| Debt/Equity Ratio | 4.0% |
How did 688046 perform over the long term?
See historical performance and comparison